Pfizer, BioNTech vaccine starts late-stage human trial
SCIENCE

Pfizer, BioNTech vaccine starts late-stage human trial

Pfizer, BioNTech vaccine starts late-stage human trial

A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020.

-/-

If trial is successful, 2 companies will seek regulatory approval as early as October

  • News Service 28 JULY 2020, 01:30AA
  • Ceo of BioNTech Ugur Sahin
  • coronavirus vaccine
  • COVID-19
SON DAKİKA

#title#